ArticleResearch and reports in urology2026
Delayed Presentation as an Independent Predictor of Erectile Dysfunction After Ischemic Priapism: A Sub-Saharan Cohort Study.
Article in Research and reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ischemic priapism is a time-sensitive urological emergency with significant consequences for erectile function. Real-world data from low-resource sub-Saharan settings, where delayed presentation is common, remain scarce. Objective: To determine outcomes of ischemic priapism management and to identify predictive factors for erectile dysfunction after treatment. Methods: Retrospective cross-sectional study conducted at the Urology Department of CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso (January 2019-December 2022). Consecutive patients aged ≥15 years with ischemic priapism were included. Erectile function was assessed using the International Index of Erectile Function 6-item version (IIEF-6), a validated 6-item questionnaire scored from 1 to 30, with scores ≥26 indicating no erectile dysfunction. IIEF-6 was recorded at diagnosis (recalled by the patient) and at last follow-up. Patients were stratified by treatment delay (<24 h, 24-48 h, >48 h). Multivariate logistic regression identified independent predictors of erectile dysfunction. Results: Of 58 patients admitted, 41 were included (mean age 31.2 ± 8.9 years). Sickle cell hemoglobinopathies (SS and SC genotypes) were identified in 46.3% of cases. The mean consultation delay was 85.3 hours. The mean IIEF-6 score declined significantly from 28.6 pre-event to 16.7 post-treatment (p<0.001). Only 29.3% of patients retained erectile function sufficient for intercourse. In multivariate analysis, treatment delay >48 hours was the sole independent predictor of erectile dysfunction (adjusted OR = 13.7; 95% CI: 2.4-76.4; p = 0.0005). Conclusion: Treatment delay beyond 48 hours is the primary independent predictor of erectile dysfunction following ischemic priapism, regardless of patient characteristics or treatment modality. These findings underscore the urgent need for patient education and improved access to emergency urological care in sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.